Authors:
SANDERSON PEJ
CUTRONA KJ
DORSEY BD
DYER DL
MCDONOUGH CM
NAYLOROLSEN AM
CHEN IW
CHEN ZG
COOK JJ
GARDELL SJ
KRUEGER JA
LEWIS SD
LIN JH
LUCAS BJ
LYLE EA
LYNCH JJ
STRANIERI MT
VASTAG K
SHAFER JA
VACCA JP
Citation: Pej. Sanderson et al., L-374,087, AN EFFICACIOUS, ORALLY BIOAVAILABLE, PYRIDINONE ACETAMIDE THROMBIN INHIBITOR, Bioorganic & medicinal chemistry letters, 8(7), 1998, pp. 817-822
Authors:
LUMMA WC
WITHERUP KM
TUCKER TJ
BRADY SF
SISKO JT
NAYLOROLSEN AM
LEWIS SD
LUCAS BJ
VACCA JP
Citation: Wc. Lumma et al., DESIGN OF NOVEL, POTENT, NONCOVALENT INHIBITORS OF THROMBIN WITH NONBASIC P-1 SUBSTRUCTURES - RAPID STRUCTURE-ACTIVITY STUDIES BY SOLID-PHASE SYNTHESIS, Journal of medicinal chemistry, 41(7), 1998, pp. 1011-1013
Authors:
BRADY SF
STAUFFER KJ
LUMMA WC
SMITH GM
RAMJIT HG
LEWIS SD
LUCAS BJ
GARDELL SJ
LYLE EA
APPLEBY SD
COOK JJ
HOLAHAN MA
STRANIERI MT
LYNCH JJ
LIN JH
CHEN IW
VASTAG K
NAYLOROLSEN AM
VACCA JP
Citation: Sf. Brady et al., DISCOVERY AND DEVELOPMENT OF THE NOVEL POTENT ORALLY-ACTIVE THROMBIN INHIBITOR N-(9-HYDROXY-9-FLUORENECARBOXY)PROLYL TRANS-4-AMINOCYCLOHEXYLMETHYL AMIDE (L-372,460) - COAPPLICATION OF STRUCTURE-BASED DESIGN AND RAPID MULTIPLE ANALOG SYNTHESIS ON SOLID SUPPORT, Journal of medicinal chemistry, 41(3), 1998, pp. 401-406
Authors:
SANDERSON PEJ
LYLE TA
CUTRONA KJ
DYER DL
DORSEY BD
MCDONOUGH CM
NAYLOROLSEN AM
CHEN IW
CHEN ZG
COOK JJ
COOPER CM
GARDELL SJ
HARE TR
KRUEGER JA
LEWIS SD
LIN JH
LUCAS BJ
LYLE EA
LYNCH JJ
STRANIERI MT
VASTAG K
YAN YW
SHAFER JA
VACCA JP
Citation: Pej. Sanderson et al., EFFICACIOUS, ORALLY BIOAVAILABLE THROMBIN INHIBITORS BASED ON 3-AMINOPYRIDINONE OR 3-AMINOPYRAZINONE ACETAMIDE PEPTIDOMIMETIC TEMPLATES, Journal of medicinal chemistry, 41(23), 1998, pp. 4466-4474
Authors:
TUCKER TJ
BRADY SF
LUMMA WC
LEWIS SD
GARDELL SJ
NAYLOROLSEN AM
YAN YW
SISKO JT
STAUFFER KJ
LUCAS BJ
LYNCH JJ
COOK JJ
STRANIERI MT
HOLAHAN MA
LYLE EA
BASKIN EP
CHEN IW
DANCHECK KB
KRUEGER JA
COOPER CM
VACCA JP
Citation: Tj. Tucker et al., DESIGN AND SYNTHESIS OF A SERIES OF POTENT AND ORALLY BIOAVAILABLE NONCOVALENT THROMBIN INHIBITORS THAT UTILIZE NONBASIC GROUPS IN THE P1 POSITION, Journal of medicinal chemistry, 41(17), 1998, pp. 3210-3219
Authors:
LEWIS SD
LUCAS BJ
BRADY SF
SISKO JT
CUTRONA KJ
SANDERSON PEJ
FREIDINGER RM
MAO SS
GARDELL SJ
SHAFER JA
Citation: Sd. Lewis et al., CHARACTERIZATION OF THE 2-STEP PATHWAY FOR INHIBITION OF THROMBIN BY ALPHA-KETOAMIDE TRANSITION-STATE ANALOGS, The Journal of biological chemistry, 273(9), 1998, pp. 4843-4854
Authors:
TUCKER TJ
LUMMA WC
LEWIS SD
GARDELL SJ
LUCAS BJ
SISKO JT
LYNCH JJ
LYLE EA
BASKIN EP
WOLTMANN RF
APPLEBY SD
Citation: Tj. Tucker et al., SYNTHESIS OF A SERIES OF POTENT AND ORALLY BIOAVAILABLE THROMBIN INHIBITORS THAT UTILIZE 3,3-DISUBSTITUTED PROPIONIC-ACID DERIVATIVES IN THE P-3 POSITION, Journal of medicinal chemistry, 40(22), 1997, pp. 3687-3693
Authors:
TUCKER TJ
LUMMA WC
LEWIS SD
GARDELL SJ
LUCAS BJ
BASKIN EP
WOLTMANN R
LYNCH JJ
LYLE EA
APPLEBY SD
CHEN IW
DANCHECK KB
VACCA JP
Citation: Tj. Tucker et al., POTENT NONCOVALENT THROMBIN INHIBITORS THAT UTILIZE THE UNIQUE AMINO-ACID D-DICYCLOHEXYLALANINE IN THE P3 POSITION - IMPLICATIONS ON ORAL BIOAVAILABILITY AND ANTITHROMBOTIC EFFICACY, Journal of medicinal chemistry, 40(11), 1997, pp. 1565-1569
Citation: Bj. Lucas, THE 2ND EPISTEMIC WAY REVISITED - REPLY TO PROFESSOR BEARD 'PROFESSORLUCAS ON OMNISCIENCE', International journal for philosophy of religion, 42(3), 1997, pp. 143-162